CN1300581C - Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 - Google Patents
Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 Download PDFInfo
- Publication number
- CN1300581C CN1300581C CNB031344194A CN03134419A CN1300581C CN 1300581 C CN1300581 C CN 1300581C CN B031344194 A CNB031344194 A CN B031344194A CN 03134419 A CN03134419 A CN 03134419A CN 1300581 C CN1300581 C CN 1300581C
- Authority
- CN
- China
- Prior art keywords
- antibody
- detection
- sars coronavirus
- layer
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000315672 SARS coronavirus Species 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 238000003745 diagnosis Methods 0.000 title claims description 17
- 238000000034 method Methods 0.000 title abstract description 14
- 238000001514 detection method Methods 0.000 claims abstract description 60
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000010931 gold Substances 0.000 claims abstract description 42
- 229910052737 gold Inorganic materials 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 17
- 239000000427 antigen Substances 0.000 claims abstract description 16
- 108091007433 antigens Proteins 0.000 claims abstract description 16
- 102000036639 antigens Human genes 0.000 claims abstract description 16
- 210000002966 serum Anatomy 0.000 claims abstract description 12
- 238000002372 labelling Methods 0.000 claims description 18
- 239000000084 colloidal system Substances 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 13
- 239000001913 cellulose Substances 0.000 claims description 12
- 229920002678 cellulose Polymers 0.000 claims description 12
- 239000013049 sediment Substances 0.000 claims description 9
- 239000003365 glass fiber Substances 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000010353 genetic engineering Methods 0.000 claims description 5
- 241000711573 Coronaviridae Species 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 241001494479 Pecora Species 0.000 claims description 4
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 2
- 229940038773 trisodium citrate Drugs 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract 5
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 10
- 239000007921 spray Substances 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 4
- 230000002745 absorbent Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031344194A CN1300581C (zh) | 2003-07-22 | 2003-07-22 | Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031344194A CN1300581C (zh) | 2003-07-22 | 2003-07-22 | Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1570638A CN1570638A (zh) | 2005-01-26 |
CN1300581C true CN1300581C (zh) | 2007-02-14 |
Family
ID=34470190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031344194A Expired - Fee Related CN1300581C (zh) | 2003-07-22 | 2003-07-22 | Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1300581C (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220381778A1 (en) * | 2019-11-15 | 2022-12-01 | Abbott Rapid Diagnostics International Unlimited Company | Device for Digital Read of Lateral Flow Assay |
CN111413500A (zh) * | 2020-02-12 | 2020-07-14 | 谱尼测试集团北京检验认证科学研究院有限公司 | 一种新型冠状病毒2019-nCoV抗原胶体金检测技术 |
CN111187354B (zh) * | 2020-02-20 | 2020-11-27 | 北京新创生物工程有限公司 | 新型冠状病毒(SARS-CoV-2)IgM/IgG抗体检测试剂盒 |
CN111190012A (zh) * | 2020-02-22 | 2020-05-22 | 南京申基医药科技有限公司 | 一种用于新型冠状病毒检测的稀土上转换荧光纳米试纸条及其制备方法 |
CN111443196A (zh) * | 2020-02-27 | 2020-07-24 | 深圳市绿诗源生物技术有限公司 | 一种新冠病毒抗体检测卡和制作方法 |
CN113341136A (zh) * | 2020-03-01 | 2021-09-03 | 上海雄图生物科技有限公司 | 一种快速筛查新型冠状病毒的检测方法 |
CN111378018B (zh) * | 2020-03-28 | 2021-01-19 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种检测新型冠状病毒抗体的试纸条及其制备方法和应用 |
CN111398603B (zh) * | 2020-03-28 | 2021-01-15 | 江苏省疾病预防控制中心(江苏省公共卫生研究院) | 一种用于检测新型冠状病毒抗体的试纸条、制备方法及其应用 |
CN111781349B (zh) * | 2020-04-03 | 2022-04-22 | 中国科学院苏州纳米技术与纳米仿生研究所 | 能够预测covid-19患者预后的诊断试剂盒 |
CN111693713A (zh) * | 2020-04-09 | 2020-09-22 | 泰州市人民医院 | 一种胶体金法检测新型冠状病毒IgM的检测卡及其制备方法 |
CN111551708A (zh) * | 2020-05-13 | 2020-08-18 | 常州领航量子生物医疗科技有限公司 | 特异性抗体的检测标记物、其制备方法、其应用及试剂盒 |
CN113740538A (zh) * | 2020-05-27 | 2021-12-03 | 复旦大学 | 一种检测SARS-CoV-2新型冠状病毒IgM/IgG抗体的方法和产品 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0481020A1 (en) * | 1989-07-06 | 1992-04-22 | Secr Health Brit | IMMUNOASSAY METHOD WITH MONEY ENRICHMENT AND GOLD LABELING. |
CN2442272Y (zh) * | 2000-09-18 | 2001-08-08 | 王冰 | Torch病原体检测生物芯片 |
-
2003
- 2003-07-22 CN CNB031344194A patent/CN1300581C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0481020A1 (en) * | 1989-07-06 | 1992-04-22 | Secr Health Brit | IMMUNOASSAY METHOD WITH MONEY ENRICHMENT AND GOLD LABELING. |
CN2442272Y (zh) * | 2000-09-18 | 2001-08-08 | 王冰 | Torch病原体检测生物芯片 |
Also Published As
Publication number | Publication date |
---|---|
CN1570638A (zh) | 2005-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU748387B2 (en) | Neutralization of polycations in a chromatographic device for whole blood use | |
EP1327885B1 (en) | A kit for the simultaneous diagnosis of a plurality of infectious diseases and a method for preparation of it | |
CN104697988B (zh) | 检测丙型肝炎病毒抗体的试剂盒及其检测方法和应用 | |
CN100582781C (zh) | 联合检测hbv前s1抗原和核心抗原的方法及诊断试剂盒 | |
Bradley et al. | Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus | |
CN1300581C (zh) | Sars病毒抗体检测方法及快速诊断试剂盒和制备方法 | |
CN103235120B (zh) | 一种复合检测戊型肝炎病毒抗体谱的试剂盒及其应用 | |
Gomara et al. | Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology | |
JPH07117536B2 (ja) | 体液中の特異的に結合可能の物質の検出方法及びリガンド受容体 | |
CN1245561A (zh) | 抗原特异性lgG的检测 | |
JPS62249999A (ja) | 非a非b型ウイルス性肝炎検出用試薬および免疫酵素法による前記肝炎の診断法 | |
CN1673749A (zh) | Hiv病毒抗体/抗原诊断试剂盒及其制备方法、检测方法 | |
CA2266747A1 (en) | Diagnostic test devices with improved fluid movement and resistance to interferences | |
EP1712917A1 (en) | Simple membrane assay method and kit | |
CN1159580C (zh) | 胶体金层析法检测sars冠状病毒抗原的试剂 | |
PT85992B (pt) | Processo para a preparacao de um agente de determinacao de anticorpos do virus da deficiencia imunitaria humana (hiv) e processo de determinacao de anti-hiv mediante o uso deste agente | |
CN1725012A (zh) | 禽流感病毒抗原检测方法及其金标快速诊断试剂盒和制备方法 | |
CN109738642A (zh) | 双抗原夹心法检测免疫球蛋白m的试剂盒及其检测方法 | |
WO1999056128A1 (en) | Immunoassay with mixed peptides | |
CN1197927A (zh) | 一种直接检测血清乙肝病毒核心抗原试剂 | |
JPH09171019A (ja) | アデノウイルス抗原検出キット | |
Richardson et al. | Further evaluation of factors affecting a rapid ELISA procedure for detection of IgG antibodies to Candida albicans | |
JPH09511057A (ja) | 被検体の検出 | |
CN2453444Y (zh) | 基于抗原-抗体反应原理的固相免疫检测用试纸 | |
JPH0266460A (ja) | 抗体を測定する方法および試薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LANZHOU YAHUA BIOTECH. CO., LTD. Free format text: FORMER OWNER: LI KESHENG Effective date: 20110823 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110823 Address after: 730050, Gansu, Lanzhou province Qilihe District No. 335 stone ditch, Fu Xi Hotel, office building, 7 floor Patentee after: LANZHOU YAHUA BIOTECH CO.,LTD. Address before: 730050, room 24, No. 704 East West Lake street, Qilihe District, Gansu, Lanzhou Patentee before: Li Kesheng |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070214 Termination date: 20170722 |
|
CF01 | Termination of patent right due to non-payment of annual fee |